These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 34666923)

  • 41. Role of antiseptics in the prevention and treatment of infections in nursing homes.
    Alves PJ; Gryson L; Hajjar J; Lepelletier D; Reners M; Rodríguez Salazar J; Simon A
    J Hosp Infect; 2023 Jan; 131():58-69. PubMed ID: 36216172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dental Practitioners' Knowledge, Attitude and Practices for Mouthwash Use Amidst the COVID-19 Pandemic.
    Imran E; Khurshid Z; Adanir N; Ashi H; Almarzouki N; Baeshen HA
    Risk Manag Healthc Policy; 2021; 14():605-618. PubMed ID: 33623451
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial.
    Sánchez Barrueco Á; Mateos-Moreno MV; Martínez-Beneyto Y; García-Vázquez E; Campos González A; Zapardiel Ferrero J; Bogoya Castaño A; Alcalá Rueda I; Villacampa Aubá JM; Cenjor Español C; Moreno-Parrado L; Ausina-Márquez V; García-Esteban S; Artacho A; López-Labrador FX; Mira A; Ferrer MD
    Emerg Microbes Infect; 2022 Dec; 11(1):1833-1842. PubMed ID: 35796097
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An exploratory study of drug concentration and inhibitory effect of cetylpyridinium chloride buccal tablets on SARS-CoV-2 infection among 10 Chinese subjects.
    Li Y; Xie Z; Chen L; Liu X; Li S; Ye S; Tang H; Lee C; Gu Q; Men F; Zhang J; Hu D; Jiang Y; Wang X; Wang Q; Feng Y; Niu S; Liu Y; Fang Y
    Fundam Clin Pharmacol; 2024 Jun; 38(3):579-587. PubMed ID: 37985697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Salivary and Nasal Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses (BBCovid): A structured summary of a study protocol for a randomised controlled trial.
    Carrouel F; Viennot S; Valette M; Cohen JM; Dussart C; Bourgeois D
    Trials; 2020 Nov; 21(1):906. PubMed ID: 33138848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How does antiseptic mouthwashes against SARS-COV-2 affect the bond strength of universal adhesive to enamel?
    Özduman ZC; Oglakci B; Doğan M; Deger C; Eliguzeloglu Dalkilic E
    Microsc Res Tech; 2022 Mar; 85(3):1199-1208. PubMed ID: 34913536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preprocedural mouthwashes for infection control in dentistry-an update.
    Weber J; Bonn EL; Auer DL; Kirschneck C; Buchalla W; Scholz KJ; Cieplik F
    Clin Oral Investig; 2023 Jun; 27(Suppl 1):33-44. PubMed ID: 37079156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Considerations for povidone-iodine antisepsis in pediatric nasal and pharyngeal surgery during the COVID-19 pandemic.
    Chorney SR; Rizzi MD; Dedhia K
    Am J Otolaryngol; 2020; 41(6):102737. PubMed ID: 32979667
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of mouth rinsing and gargling with mouthwash containing povidone-iodine and hydrogen peroxide on the cycle threshold value of Severe Acute Respiratory Syndrome Coronavirus 2: A randomized controlled trial of asymptomatic and mildly symptomatic patients.
    Sulistyani LD; Julia V; Soeprapto A; Swari RP; Rosmanato F; Haryanto B; Cahyarini C; Panjaitan R; Maharani DA
    F1000Res; 2022; 11():1238. PubMed ID: 38988895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is chlorhexidine mouthwash effective in lowering COVID-19 viral load? A systematic review.
    Rahman GS; Alshetan AAN; Alotaibi SSO; Alaskar BMI; Baseer MA
    Eur Rev Med Pharmacol Sci; 2023 Jan; 27(1):366-377. PubMed ID: 36647885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of Pre-Procedural Mouthwashes against SARS-CoV-2: A Systematic Review of Randomized Controlled Trials.
    Garcia-Sanchez A; Peña-Cardelles JF; Ruiz S; Robles F; Ordonez-Fernandez E; Salgado-Peralvo AO; Balloch J; Simon JC
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35330016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized clinical trial to assess the impact of oral intervention with cetylpyridinium chloride to reduce salivary SARS-CoV-2 viral load.
    Tarragó-Gil R; Gil-Mosteo MJ; Aza-Pascual-Salcedo M; Alvarez MJL; Ainaga RR; Gimeno NL; Viñuales RF; Fernández YM; Marco JM; Bolsa EA; Sancho JB; Cajo SA; Perez-Zsolt D; Raïch-Regué D; Muñoz-Basagoiti J; Izquierdo-Useros N; Pociello VB; León R; Peris DS
    J Clin Periodontol; 2023 Mar; 50(3):288-294. PubMed ID: 36345827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Virucidal Activity of Different Mouthwashes Using a Novel Biochemical Assay.
    Rodríguez-Casanovas HJ; la Rosa M; Bello-Lemus Y; Rasperini G; Acosta-Hoyos AJ
    Healthcare (Basel); 2021 Dec; 10(1):. PubMed ID: 35052227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Virucidal Activity of Different Mouthwashes against the Salivary Load of SARS-CoV-2: A Narrative Review.
    Garcia-Sanchez A; Peña-Cardelles JF; Salgado-Peralvo AO; Robles F; Ordonez-Fernandez E; Ruiz S; Végh D
    Healthcare (Basel); 2022 Mar; 10(3):. PubMed ID: 35326947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro.
    Muñoz-Basagoiti J; Perez-Zsolt D; León R; Blanc V; Raïch-Regué D; Cano-Sarabia M; Trinité B; Pradenas E; Blanco J; Gispert J; Clotet B; Izquierdo-Useros N
    J Dent Res; 2021 Oct; 100(11):1265-1272. PubMed ID: 34282982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is there scientific evidence of the mouthwashes effectiveness in reducing viral load in Covid-19? A systematic review.
    Cavalcante-Leão BL; de Araujo CM; Basso IB; Schroder AG; Guariza-Filho O; Ravazzi GC; Gonçalves FM; Zeigelboim BS; Santos RS; Stechman-Neto J
    J Clin Exp Dent; 2021 Feb; 13(2):e179-e189. PubMed ID: 33575003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cetylpyridinium Chloride-Containing Mouthwashes Show Virucidal Activity against Herpes Simplex Virus Type 1.
    Riveira-Muñoz E; Garcia-Vidal E; Bañó-Polo M; León R; Blanc V; Clotet B; Ballana E
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of mouthrinses in reducing oral SARS-COV-2 load: a review.
    Pannuti CM; Reis INRD; Souza NV; Souto MLS; Silva CGB; Bezinelli LM; Machado CM; Romito GA; Villar CC
    Braz Oral Res; 2023; 37():e038. PubMed ID: 37132726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Could mouth rinses be an adjuvant in the treatment of SARS-CoV-2 patients? An appraisal with a systematic review.
    Gandhi G; Thimmappa L; Upadhya N; Carnelio S
    Int J Dent Hyg; 2022 Feb; 20(1):136-144. PubMed ID: 34628705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiviral Activity of Reagents in Mouth Rinses against SARS-CoV-2.
    Carrouel F; Gonçalves LS; Conte MP; Campus G; Fisher J; Fraticelli L; Gadea-Deschamps E; Ottolenghi L; Bourgeois D
    J Dent Res; 2021 Feb; 100(2):124-132. PubMed ID: 33089717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.